Citigroup’s NeueHealth NEUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2
Closed -$10 5983
2024
Q3
$10 Hold
2
﹤0.01% 5621
2024
Q2
$11 Hold
2
﹤0.01% 5512
2024
Q1
$13 Sell
2
-5,035
-100% -$44.9K ﹤0.01% 5558
2023
Q4
$38.4K Buy
5,037
+5,005
+15,641% +$33.6K ﹤0.01% 4658
2023
Q3
$191 Sell
32
-212
-87% -$2.18K ﹤0.01% 5326
2023
Q2
$2.98K Buy
+244
New +$3.23K ﹤0.01% 5243
2023
Q1
Sell
-16
Closed -$846 5917
2022
Q4
$846 Sell
16
-20
-56% -$1.45K ﹤0.01% 5427
2022
Q3
$3K Sell
36
-382
-91% -$50.7K ﹤0.01% 5427
2022
Q2
$61K Buy
418
+295
+240% +$42.9K ﹤0.01% 4456
2022
Q1
$19K Sell
123
-1,808
-94% -$402K ﹤0.01% 5189
2021
Q4
$532K Buy
1,931
+1,832
+1,851% +$846K ﹤0.01% 3742
2021
Q3
$65K Buy
99
+81
+450% +$71.3K ﹤0.01% 4604
2021
Q2
$25K Buy
+18
New +$24.7K ﹤0.01% 5187

Other funds holding NEUE

Citigroup's NEUE Position: Q4 2024 in Review

Citigroup sold out of NeueHealth (NEUE) in Q4 2024, closing a stake of 2 shares — an estimated $10 sold.

Citigroup first reported a position in NEUE in Q2 2021 and held it in 13 quarters. The position peaked at $532K in Q4 2021. 38 funds tracked by Wall St. Rank hold NEUE as of Q4 2024.

  • Citigroup reported no remaining NeueHealth position as of Q4 2024 after selling out during the quarter.
  • Citigroup sold 2 NeueHealth shares in Q4 2024, an estimated $10.
  • Citigroup first reported a position in NeueHealth in Q2 2021 and held it in 13 quarters.
  • Citigroup's NeueHealth position peaked at $532K in Q4 2021.
  • 38 funds tracked by Wall St. Rank held NeueHealth as of Q4 2024.

Based on Citigroup's 13F filing for Q4 2024, filed 12 Feb 2025.